HPV16 E5 Protein and HLA-I Surface Expression
Author Information
Author(s): Myriam Gruener, Ignacio G Bravo, Frank Momburg, Angel Alonso, Pascal Tomakidi
Primary Institution: German Cancer Research Center, Heidelberg, Germany
Hypothesis
The chaperone calnexin is involved in the E5-mediated down-regulation of HLA-I surface expression.
Conclusion
HPV16 E5 down-regulates HLA-I surface expression through a mechanism involving calnexin.
Supporting Evidence
- HPV16 E5 expression leads to a significant down-regulation of HLA-I surface expression.
- Calnexin is necessary for the E5-mediated down-regulation of HLA-I.
- Mutant E5 proteins that do not bind calnexin fail to down-regulate HLA-I.
- Co-immunoprecipitation experiments show that E5 and calnexin interact.
- Down-regulation of HLA-I was not observed in calnexin-deficient cells.
Takeaway
The HPV16 E5 protein can make it harder for the body to recognize infected cells by lowering the amount of a protein called HLA-I on their surface, but it only works when another protein, calnexin, is present.
Methodology
Cells were transfected with HPV16 E5 and analyzed for HLA-I surface expression using flow cytometry and immunoprecipitation.
Potential Biases
Potential bias in the interpretation of results due to reliance on specific experimental conditions.
Limitations
The study primarily focuses on specific cell lines and may not fully represent all cellular contexts.
Participant Demographics
Human cell lines were used, including calnexin-expressing and calnexin-deficient variants.
Statistical Information
P-Value
p ≤ 0.001
Statistical Significance
p ≤ 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website